DNA polymerase mu
DNA polymerase mu (Pol μ) is a unique DNA polymerase that is involved in the process of non-homologous end joining (NHEJ), a mechanism used by cells to repair double-strand breaks in DNA. Unlike most DNA polymerases, Pol μ possesses the ability to perform template-independent DNA synthesis, making it crucial for the repair of breaks that have incompatible or damaged ends. This enzyme is a member of the X family of DNA polymerases, which also includes Pol β, Pol λ, and TdT.
Function
Pol μ's primary role is in the repair of double-strand breaks in DNA through NHEJ. This pathway is essential for maintaining genomic stability, especially in the immune system during V(D)J recombination, a process that generates the diversity of antibodies. Unlike homologous recombination, NHEJ does not require a homologous template, making Pol μ's template-independent activity particularly valuable. Pol μ can add nucleotides at the break site, facilitating the bridging and eventual ligation of the DNA ends.
Structure
The structure of Pol μ shares similarities with other members of the X family of DNA polymerases, including a BRCT domain that is thought to be involved in protein-protein interactions necessary for its function in DNA repair. However, Pol μ also exhibits unique structural features that enable its template-independent synthesis capabilities, including a highly flexible active site.
Clinical Significance
Mutations in the gene encoding Pol μ have been associated with an increased susceptibility to various cancers, highlighting the enzyme's role in preventing genomic instability. Additionally, due to its role in V(D)J recombination, alterations in Pol μ activity can impact the immune system's ability to generate antibody diversity, potentially leading to immunodeficiency disorders.
Research
Research on Pol μ is ongoing, with studies aimed at elucidating its precise mechanisms of action, its interactions with other proteins involved in DNA repair, and its potential as a target for cancer therapy. Understanding the detailed function of Pol μ could lead to novel approaches to enhance DNA repair in diseases characterized by genomic instability.
See Also
References
<references />
| Y-STR Name |
| Haplotype |
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
